1Kaufman HE,Martola E,Dohlman C.Use of 5-iodo-2-deoxyuridine (IDU) in treatment of herpes simplex keratitis.Arch Ophthalmol,1962,68:235-239.
2Wilson FM.Adverse external ocular effects of topical ophthalmic medications.Surv Ophthalmol,1979,24:57-58.
3Takamura E,Suzuke M,Kasagi Y.Adverse reaction of 3% acyclovir ointment.Atarashii Ganka,1986,3:1631-1634.
4Herpetic Eye Disease Study Group.Oral acyclovir for herpes simplex virus eye disease.Arch Ophthalmol,2000,118(8):1030-1036.
5Collins P,Darby G.Laboratory studies of herpes simplex virus strains resistant to acyclovir.Rev Med Virol,1991,1:19-28.
6Maudgal PC,Erik DC.Evaluation of bromovinyl deoxyuridine herpes simplex keratites.Arch Ophthalmol,1985,103:1393-1397.
7Maudgal PC,Watler N,Erik DC.Oral and topical treatment of experimental herpes simplex iritis with Bromovinyl deoxyuridine.Arch Ophthalmol,1982,100:1337-1340.
8Maudgal PC,Eric DC.Effects of phosphonylmethoxyalkyl-purine and-pyrimidine derivatives on TK+and TK-HSV-1 keratites in rabbits.Antiviral Res,1991,16:93-100.
9Eric DC.Therapeutic potential of HPMPC as an antiviral drug.Rev Med Virol,1993,3:85-96.
10Kaufman HE,Varnell ED,Thompson HW.Cidofovir and experimental herpetic stromal disease.Arch Ophthalmol,1999,117(7):925-928.
5Uchoa UB, Rezende RA, Carrasco MA, et al. Long-termacyclovir use to prevent recurrent ocular herpes simplex virus infection. Arch Ophthalmol, 2003, 121 (12): 1702-1704.
6Akova YA, Onat M,Duman S. Efficacy of low dose and longterm oral acyclovir therapy after penetrating keratoplasty for herpes simplex kratitis. Ocul Immunool Inflam, 1999, 7(1): 51-60.
7Herpeetic Eye Disease Study Group. Aeyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med, 1998, 339(5) : 300-306.
8Gerenficca W, Fonte C, Vecchio S. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms [J ]. Blood Transfus, 2010, 8 (2): 107-112.
9Allen SJ, Mort KR, Ljubimov AV, et al. Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mlce[J]. Virology, 2010, 399 (1): 11-22.
10Bauer D, Lu M, Wasmuth S, et al. lmmunomedulation by topical particle-mediated administration of eytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense [J]. Graefes Arch Clio Exp Ophthalmol, 2006, 244 (2) : 216-25.
